chrisvoncsefalvay/vaers-outcomes huggingface dataset:
painful 2" red welt with a white ring around it; painful 2" red welt with a white ring around it; sore lymph nodes under arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21Apr2021 14:00 (Lot number: EW0169) at the age of 56 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8734, Location of injection: Arm Left), administration date: 31Mar2021, when the patient was 56 years old, for COVID-19 Immunization. The following information was reported: URTICARIA (non-serious), PAIN (non-serious) all with onset 2021, outcome "recovered" (2021) and all described as "painful 2" red welt with a white ring around it"; LYMPH NODE PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "sore lymph nodes under arm". Therapeutic measures were taken as a result of urticaria, pain, lymph node pain.  Additional information: On the 2nd dose, she had a very painful 2" red welt with a white ring around it for a few days and sore lymph nodes under arm. She took Benadryl and Ibuprofen, and it went away. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Patient has an extremely swollen upper arm, ache/heat in the arm, fever and increased heart rate.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. A 77 year-old female patient received bnt162b2 (BNT162B2), administration date 18Feb2021 (Batch/Lot number: unknown) as dose 2, single for Covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: RITUXIMAB. Vaccination history included: Bnt162b2 (1st dose), administration date: 27Jan2021, when the patient was 77 years old, for Covid-19 immunization. The following information was reported: B-LYMPHOCYTE COUNT DECREASED (non-serious), outcome "unknown", described as "B cells are low"; POTENTIATING DRUG INTERACTION (non-serious), outcome "unknown", described as "Taking another drug that is proven to compromise the effectiveness of the vaccine which is called Rituximab". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Reporter wanted to know how you measure the antibodies and B cell level in the person after vaccination. How much it should be for the vaccine to be effective. Reporter wanted to know if his wife can take the series again/booster dose if it was not effective before due to interaction. Reporter (withheld) called on behalf of his wife who got the first dose of the vaccine on January 27th and the second dose on February 18th. His wife has been taking another drug that is proven to compromise the effectiveness of the vaccine which is called Rituximab for several years now every 6 months. He wants to talk to a health professional who can assist him regarding his concern. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On March 15th, 2018, my 5 year old daughter received the DTap vaccine. On March 28th, she began to complain about a swollen ankle. After taking her to the doctors and having X-Rays done, the doc determined she must have just sprained her ankle while playing. 2 days later on March 30th, she began complaining about her elbow and how much it hurt. It wasn't until later that day did I realize how swollen it was. It wasn't until bedtime when I went to put her pajamas on did I notice a lot of small bruises all over her legs and feet. I rushed her to the emergency room to be seen. After ruling out any injuries to her elbow with another X-Ray, we were told that she had developed Henoch-Schonlein Purpura (HSP). Her condition had gotten so bad that she couldn't walk and she would cry when touched. Her bruising had continued to worsen with every passing minute. She began to swell in the hands and arms. The emergency room doctor admitted her for an overnight stay to be monitored and for pain management. The next morning they repeated her blood work to ensure that kidneys were functioning properly and that there wasn't any infections. Once we were discharged, we had a follow up appointment with our family practice doctor 2 days later. They advised a weekly urine test for the next month and then every 2 weeks for the next 2 months to monitor her kidney function. After a couple days, her swelling went down and about a week and a half later her bruises finally healed. She has had no other reactions following this event.
parent states pt ran fever during noc p/vax;temp 108 ax-today @ MD office t102.5;
Approx. 30 minutes after receiving second dose of Moderna vaccine pt. reported feeling pre-ictal. Reports hx of seizure disorder with recent increase in frequency. Last seizure one week ago. Patient was asked to sit down as she was trying to leave the vaccine clinic. Once seated, she began to have a grand mal seizure and was assisted to floor by two medical staff. HR 107 O2 sat. 93% BP 150/100. Within three minutes O2 sat. increased to 100% HR 120. VS monitored and supported by medical team as she started to become alert and could state where she was. At 2:20pm had a second grand mal seizure. EMS arrived to transport pt. and appeared to have a third seizure just prior to be moved to the cot for transport. HR 110 O
pt became faint immed p/inject, cyanotic 5 resp x 2-3 second, sl involuntary muscle contractions x 2-3 seconds, responded to verbal stim; resp resumed nl; carotid pulses remain 50-60BPM throughout episode;
A pharmacy technician reported that an adult patient who had undergone a bone marrow transplantation received an injection of Hib-TITER along with other unspecified vaccines and subsequently complained of feeling sick and crummy. No further information was available at the date of this report.
6 weeks pregnant HCW, states she received COVID vaccine on 12/19/2020 around 1400 and at around 2200 last night started to have migraine headache and neurological symptoms , claimed that she couldn't find words to complete sentences and having numbness on the R hand- patient went to  ED- per patient symptoms resolved after less than an hour. Now she is concerned if she should take the second dose,
Case number PHEH2013US021737 is an initial spontaneous report from the pharmacist received on 15 Oct 2013. This report refers to a 39-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 13454P) on 14 Oct 2013. On the same date, after vaccination she experienced flu like symptoms including chills and headache. She was transferred to hospital for monitoring and was hospitalized for less than 24 hours. The outcome of the events reported as condition unchanged. The events were reported as serious (hospitalization) by the reporter. The causality of the events was not reported.
1/18/06 child presented with 20-30 chicken pox lesions on trunk, face, arms and legs.
4/4/09 Sat. noon sudden onset with severe back pain & body ache like the flu. Diarrhea    started - went to bed - 200 went to ER. Received a bag of fluids of IV ZOFRAN & 1 MG DILAUDID & felt better. 4/5/06 woke up felt weak, but better - as day progressed weakness, 5x for med stool then loose again. Poor appetite. Ate cherries, kept them down! 4-6-09 ER visit again. Diagnosed 4/7/09 as Virus.
Dermographia uticartia on palms of hands soles of feet neck  and full trunk; intermittent fever; joint pain; exhaustion; tonsil stones; allergic gravel like welds in esophagus; itching eustachian tubes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Aug2021 11:00 (Batch/Lot number: unknown) at the age of 49 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "MTHFR gene mutation" (unspecified if ongoing); "Sjogren's syndrome" (unspecified if ongoing); "TBI" (unspecified if ongoing); "corn allergy" (unspecified if ongoing); "nightshades allergy" (unspecified if ongoing); "wheat allergy" (unspecified if ongoing). Concomitant medication(s) included: ADDERALL; TESTOSTERONE. Past drug history included: Codeine, reaction(s): "Allergy"; Erythromycin, reaction(s): "allergy"; Lortab, reaction(s): "allergy"; Penicillin, reaction(s): "allergy". Vaccination history included: Bnt162b2 (Dose 1, Administration time: 01:00 PM, Lot Number: Unknown, Lot unknown reason: Misplaced/discarded, Vaccine location: Left arm), administration date: 06Aug2021, when the patient was 49 years old, for COVID-19 Immunisation. The following information was reported: MECHANICAL URTICARIA (non-serious) with onset 29Aug2021 01:00, outcome "not recovered", described as "Dermographia uticartia on palms of hands soles of feet neck  and full trunk"; PYREXIA (non-serious) with onset 29Aug2021 01:00, outcome "not recovered", described as "intermittent fever"; ARTHRALGIA (non-serious) with onset 29Aug2021 01:00, outcome "not recovered", described as "joint pain"; FATIGUE (non-serious) with onset 29Aug2021 01:00, outcome "not recovered", described as "exhaustion"; TONSILLOLITH (non-serious) with onset 29Aug2021 01:00, outcome "not recovered", described as "tonsil stones"; HYPERSENSITIVITY (non-serious) with onset 29Aug2021 01:00, outcome "not recovered", described as "allergic gravel like welds in esophagus"; PRURITUS (non-serious) with onset 29Aug2021 01:00, outcome "not recovered", described as "itching eustachian tubes". The events "dermographia uticartia on palms of hands soles of feet neck and full trunk", "intermittent fever", "joint pain", "exhaustion", "tonsil stones", "allergic gravel like welds in esophagus" and "itching eustachian tubes" were evaluated at the physician office visit. Therapeutic measures were taken as a result of mechanical urticaria, pyrexia, arthralgia, fatigue, tonsillolith, hypersensitivity, pruritus.  Additional Information: The patient was an adult (18-64 Years). The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient received treatment of Loratidine 10 mg  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Right arm @ injection site developed red spot like insect bite 24 hrs after vaccine became progressively larger red hot sl swelling tender 1 1/2". Area spread out to about 4" & became itchy. Mtr called 72 hrs after immunization instructed to apply warm compresses give Motrin call in am if no change or worse.
Patient fainted and hit his head, he does not know what happened to him. We called 911, patient rejected medical care services at the hospital.
Dizziness; Increased Heart Rate; Felt dizzy; Increased Heart Rate; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy), the first episode of HEART RATE INCREASED (Increased Heart Rate), DIZZINESS (Dizziness) and the second episode of HEART RATE INCREASED (Increased Heart Rate) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced DIZZINESS (Felt dizzy) and the first episode of HEART RATE INCREASED (Increased Heart Rate). On 16-Feb-2021, the patient experienced DIZZINESS (Dizziness) and the second episode of HEART RATE INCREASED (Increased Heart Rate). On 14-Feb-2021, DIZZINESS (Felt dizzy) had resolved. At the time of the report, DIZZINESS (Dizziness) and the last episode of HEART RATE INCREASED (Increased Heart Rate) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were blood pressure and blood thinner. Treatment details was not reported by the reporter.   Reporter did not allow further contact
A Consumer report has been received concerning Vaccine exposure during pregnancy in a 34 year old, female consumer, who has been receiving nasal FLUMIST, 0.2 Millilitres, Once/Single administration. FLUMIST started during Dec-2013. The mother reporting that her daughter-in-law had the FLUMIST vaccine in Dec-2013 and found out recently that she was 8 weeks pregnant (Preferred Term: Exposure during pregnancy) (and was pregnant when she had the vaccine). Wondering what possible effect this might have on the baby. Pregnancy outcome was unknown. Pregnancy outcome was unknown. The outcome of the event of took the FLUMIST and found out she's pregnant is unknown. The report was considered to be non-serious.
VAQTA that had undergone temperature excursion was administered to a patient; No additional AE reported; This spontaneous report has been received from a healthcare worker, concerning a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications was not provided.   On an unspecified date, the patient was vaccinated with an improperly stored hepatitis a vaccine, inactivated(VAQTA) for prophylaxis, lot reported as U026782 and expiration date 28-OCT-2022 (lot number U026782 is an invalid lot number for vaccine, inactivated(VAQTA), lot U026782 does not match any company product as confirmed by lot verification team) (strength, dose and route of administration were not provided). No adverse event was reported.   The temperature excursion was reported as 49.6F during a time frame of 32 minutes. There was no previous temperature excursion.
Narrative: COVID infection following COVID vaccine vaccine series 04/22, Pfizer, dose #1 05/19 Pfizer, dose #2 08/05 COVID swab, result: detected 08/05 pt cc: chills, cough, diarrhea, fatigue, fever, headache, loss of taste or smell, rhinorrhea, dyspnea, sore throat, vomiting exposure; unknown 08/05 -08/15 pt symptoms continue 08/12 SARS-COV-2 LINEAGE result: AY .3 08/12 SARS-COV-2 CLADE results: 21A Delta 08/16 clinically resolved
Patient developed itching 10 mins post-vaccination. Itching moved from upper body to head and inside mouth. Felt slight soreness in throat 45 mins in. Took diphenhydramine 25mg. Symptoms slowly dissipated. Stayed under observation a total of 1.5 hours. No  feeling of obstruction in throat, no shortness of breath or wheezing, no rash or swelling. VS normal, physical exam normal. Slight increase in heart rtate which may have been due to Adderall.
This is a spontaneous report from a contactable consumer (patient's husband). A 74-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: ER8730, patient was 74-year-old at the time of vaccination), via an unspecified route of administration on 24Mar2021 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Cerebrovascular accident in September, back pain. Concomitant medication(s) included atorvastatin (ATORVASTATIN); oxybutynin hcl (OXYBUTYNIN HCL); morphine sulfate (MORPHINE SULPHATE); ondansetron hydrochloride (EMITIVA); lisinopril (LISINOPRIL); mirabegron (MYRBETRIQ); lactulose (ENULOSE); etoposide (ETOPOSIDE); duloxetine hydrochloride (DULOXETINE HYDROCHLORIDE); varenicline tartrate (CHANTIX); diclofenac sodium (DICLOFENAC SODIUM); ibandronate sodium (IBANDRONATE SODIUM); gabapentin (GABAPENTIN). Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6198, patient was 74-year-old at the time of vaccination), via an unspecified route of administration on 25Feb2021 as DOSE 1, SINGLE for covid-19 immunisation. Reported that patient was like a puppy with leash. I mean we change sheets over maybe something, I don't know, just it's continuously, just won't stop. On 25Apr2021, the patient experienced itchy, on 24Mar2021 at 17:00, patient experienced scratching. Therapeutic measures were taken as a result of itchy, scratching with Benadryl from super market and keep an eye again same thing so I wasn't happy about so doctor said these are severe about anybody could have so Benadryl liquids she has been drinking it. The outcomes of events were not recovered.  No follow-up attempts are possible. No further information is expected.
Pain all over body; Swelling on left arm; unable to lift arm; Dizziness while doing yard work; Pain on left arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain all over body), VACCINATION SITE SWELLING (Swelling on left arm), MOBILITY DECREASED (unable to lift arm), DIZZINESS (Dizziness while doing yard work) and VACCINATION SITE PAIN (Pain on left arm) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0441321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by the reporter.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 21-May-2021, the patient experienced PAIN (Pain all over body), VACCINATION SITE SWELLING (Swelling on left arm), MOBILITY DECREASED (unable to lift arm), DIZZINESS (Dizziness while doing yard work), VACCINATION SITE PAIN (Pain on left arm) and HEADACHE (headache).   The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PAIN (Pain all over body), VACCINATION SITE SWELLING (Swelling on left arm), MOBILITY DECREASED (unable to lift arm), DIZZINESS (Dizziness while doing yard work), VACCINATION SITE PAIN (Pain on left arm) and HEADACHE (headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant product use was not provided by the reporter.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On 16-AUG-2014 the patient was vaccinated with VARIVAX (Merck) (dose, units, route of administration, anatomical location were not reported) which was exposed to a supported temperature excursions on 15-AUG-2014. No adverse events had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
CAME TO CLINIC CONCERNED ABOUT RED LUMP ON CHILDS LEFT LEG AFTER IMMUNIZATIONS RECEIVED AT WIC. RED, WARM TO THE TOUCH, 4.5 CM IN DIAMETER. SEEN BY A DR FOR LOCALIZED REACTION.
pt in SNF; positive COVID test on 12/17/21; per death certificate, pt died in the facility with causes of death being:  cardiopulmonary arrest, COVID, chronic obstructive respiratory failure and coronary artery disease
Received 2nd dose of Pfizer COVID 19 vaccine on 8/22 after which he experienced headache, nausea and vomiting and fever to 103 (according to history). On 8/24 he experienced chest pain described as constant mid-chest pressure unrelieved by position change. On 8/25 he presented to the ED and was admitted for concerns of myocarditis. Length of stay was 2 days.
Immunization appears to have been given into the shoulder joint.  Patient experienced pain radiating down the arm and into hand by that evening. Continued for 2 days so she paid visit to her physician. MD prescribed Diclofenac gel which was given to the patient at no charge by pharmacy, and told to ice the joint. MD said return in one week.
Sore throat 10-8 to 10-14 Sneezing & running nose 10-8 to 10-14 Headache  10-9 to 10-14 Ear ache 10-8 to 10-14 COUGHING UP BLOOD 10-11 & 10-12 Excess mucus production 10-10 to ongoing
This spontaneous report was received from a pharmacist referring to a 48 year old female patient , who was a smoker (tobacco user). The patient's pertinent medical history was not reported. The patient had no relevant drug history. On 03-NOV-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose and route of administration were unknown) once, in the right arm, because she was a smoker (tobacco user). Concomitant therapies included influenza virus vaccine (unspecified) in the left arm. On 03-NOV-2015, after PNEUMOVAX 23 was given to the patient, she developed rash on the arm, below the injection site, with redness, swelling, warm to the touch and a hard knot has developed. It was stated that it was very cellulitis like. It was stated that on 04-NOV-2015, cellulitis has worsened because it had spread form the mid to the arm to the inner arm. There were no relevant laboratory data. It was also reported that a specific doctor did not prescribe this vaccine, it was a standing order at the pharmacy. At the time of the report, the outcome of cellulitis was not recovered. Additional information is not expected.
Patient was admitted on 12/17/2021 with bilateral pulmonary emboli and DVT. She received J&J COVID Vaccine and the seasonal flu vaccine on 12/19/2021 and was discharged to a skilled nursing facility on 12/23/2021. She had a cardiac arrest on 01/06/2022 and was brought to the emergency department via EMS. Patient had an active code status of DNA A2 and subsequently expired.
Redness swelling and warm to touch at injection site, cold compress to site. 7 out of 28 students had same reaction.
Developed hives 24 hours after MMR , Hepatitis A. Seen at an urgent care, no change 30m after BENADRYL. Sent to ER for observation. Discharged after a couple of hours.
Patient c/o arm swelling, warm, non tender 3-4 days after HPV #2.
Pins and needles type of sensation in left arm only. However, this tingling was spreading to the left side of face.; Minimal weakness in left arm extremity,; This is a spontaneous report from a contactable healthcare professional, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 09Jun2021 at 09:00 (at the age of 48-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient was not allergic to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Jul2021, the patient experienced pins and needles type of sensation in the left arm only. There was minimal weakness in that extremity, however, the tingling had spread to the left side of the patient's face. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pins and needles type of sensation in the left arm, minimal weakness in that extremity and the tingling had spread to the left side of the patient's face was not resolved at the time of this report.
Moderna Covid-19 Vaccine was given to this patient at 17.60 yrs of age . Patient did not suffer any adverse effect and tolerated vaccine well.
PATIENT MAY HAVE RECEIVED WRONG VACCINE. PATIENT SHOULD HAVE GOTTEN MODERNA, BUT SYSTEM SHOWS PFIZER